Axogen Inc Net Income
| AXGN Stock | USD 33.23 0.62 1.90% |
As of the 13th of February 2026, Axogen shows the Downside Deviation of 2.71, risk adjusted performance of 0.1393, and Mean Deviation of 2.29. Axogen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Axogen Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 7.767 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -9 M | -9.4 M | |
| Net Loss | -9 M | -9.4 M | |
| Net Loss | -26.1 M | -27.4 M | |
| Net Loss | (0.26) | (0.27) | |
| Net Income Per E B T | 1.15 | 1.21 |
Axogen | Net Income | Build AI portfolio with Axogen Stock |
Evaluating Axogen's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Axogen Inc's fundamental strength.
Latest Axogen's Net Income Growth Pattern
Below is the plot of the Net Income of Axogen Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Axogen Inc financial statement analysis. It represents the amount of money remaining after all of Axogen Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Axogen's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axogen's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (9.96 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Axogen Net Income Regression Statistics
| Arithmetic Mean | (15,877,597) | |
| Geometric Mean | 12,584,932 | |
| Coefficient Of Variation | (52.94) | |
| Mean Deviation | 7,002,505 | |
| Median | (14,411,144) | |
| Standard Deviation | 8,406,221 | |
| Sample Variance | 70.7T | |
| Range | 29.6M | |
| R-Value | (0.35) | |
| Mean Square Error | 66T | |
| R-Squared | 0.12 | |
| Significance | 0.16 | |
| Slope | (587,991) | |
| Total Sum of Squares | 1130.6T |
Axogen Net Income History
Other Fundumenentals of Axogen Inc
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Axogen Net Income component correlations
Axogen Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Axogen is extremely important. It helps to project a fair market value of Axogen Stock properly, considering its historical fundamentals such as Net Income. Since Axogen's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Axogen's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Axogen's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.235 | Return On Assets | Return On Equity |
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.
Axogen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Axogen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Axogen.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Axogen on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Axogen Inc or generate 0.0% return on investment in Axogen over 90 days. Axogen is related to or competes with Iradimed, InMode, Integra LifeSciences, Tandem Diabetes, Adapthealth Corp, Claritev, and Opko Health. AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection... More
Axogen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Axogen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Axogen Inc upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.71 | |||
| Information Ratio | 0.1424 | |||
| Maximum Drawdown | 23.58 | |||
| Value At Risk | (3.81) | |||
| Potential Upside | 5.76 |
Axogen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Axogen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Axogen's standard deviation. In reality, there are many statistical measures that can use Axogen historical prices to predict the future Axogen's volatility.| Risk Adjusted Performance | 0.1393 | |||
| Jensen Alpha | 0.5223 | |||
| Total Risk Alpha | 0.2887 | |||
| Sortino Ratio | 0.1762 | |||
| Treynor Ratio | 2.05 |
Axogen February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1393 | |||
| Market Risk Adjusted Performance | 2.06 | |||
| Mean Deviation | 2.29 | |||
| Semi Deviation | 2.24 | |||
| Downside Deviation | 2.71 | |||
| Coefficient Of Variation | 612.53 | |||
| Standard Deviation | 3.36 | |||
| Variance | 11.27 | |||
| Information Ratio | 0.1424 | |||
| Jensen Alpha | 0.5223 | |||
| Total Risk Alpha | 0.2887 | |||
| Sortino Ratio | 0.1762 | |||
| Treynor Ratio | 2.05 | |||
| Maximum Drawdown | 23.58 | |||
| Value At Risk | (3.81) | |||
| Potential Upside | 5.76 | |||
| Downside Variance | 7.36 | |||
| Semi Variance | 5.04 | |||
| Expected Short fall | (2.68) | |||
| Skewness | 1.37 | |||
| Kurtosis | 6.22 |
Axogen Inc Backtested Returns
Axogen appears to be very steady, given 3 months investment horizon. Axogen Inc secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18 % return per unit of risk over the last 3 months. By analyzing Axogen's technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please makes use of Axogen's Risk Adjusted Performance of 0.1393, downside deviation of 2.71, and Mean Deviation of 2.29 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Axogen holds a performance score of 14. The firm shows a Beta (market volatility) of 0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Axogen's returns are expected to increase less than the market. However, during the bear market, the loss of holding Axogen is expected to be smaller as well. Please check Axogen's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Axogen's price patterns will revert.
Auto-correlation | 0.50 |
Modest predictability
Axogen Inc has modest predictability. Overlapping area represents the amount of predictability between Axogen time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Axogen Inc price movement. The serial correlation of 0.5 indicates that about 50.0% of current Axogen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 2.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Axogen Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Axogen Inc reported net income of (9.96 Million). This is 102.92% lower than that of the Health Care Equipment & Supplies sector and 104.18% lower than that of the Health Care industry. The net income for all United States stocks is 101.75% higher than that of the company.
Axogen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axogen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axogen could also be used in its relative valuation, which is a method of valuing Axogen by comparing valuation metrics of similar companies.Axogen is currently under evaluation in net income category among its peers.
Axogen ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Axogen's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Axogen's managers, analysts, and investors.Environmental | Governance | Social |
Axogen Institutional Holders
Institutional Holdings refers to the ownership stake in Axogen that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Axogen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Axogen's value.| Shares | Assenagon Asset Management Sa | 2025-06-30 | 1 M | Dimensional Fund Advisors, Inc. | 2025-06-30 | 787.9 K | Dafna Capital Management Llc | 2025-06-30 | 741.8 K | Qube Research & Technologies | 2025-06-30 | 728.7 K | Parkman Healthcare Partners Llc | 2025-06-30 | 674.6 K | Marshall Wace Asset Management Ltd | 2025-06-30 | 641.4 K | Deutsche Bank Ag | 2025-06-30 | 585.6 K | Silvercrest Asset Management Group Llc | 2025-06-30 | 580.2 K | Tocqueville Asset Management L.p. | 2025-06-30 | 484.9 K | First Light Asset Management, Llc | 2025-06-30 | 4.5 M | Blackrock Inc | 2025-06-30 | 3.5 M |
Axogen Fundamentals
| Return On Equity | -0.0191 | ||||
| Return On Asset | 0.0121 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.67 B | ||||
| Shares Outstanding | 50.17 M | ||||
| Shares Owned By Insiders | 2.56 % | ||||
| Shares Owned By Institutions | 87.88 % | ||||
| Number Of Shares Shorted | 2.75 M | ||||
| Price To Earning | (47.07) X | ||||
| Price To Book | 13.54 X | ||||
| Price To Sales | 7.62 X | ||||
| Revenue | 187.34 M | ||||
| Gross Profit | 160.52 M | ||||
| EBITDA | 6.08 M | ||||
| Net Income | (9.96 M) | ||||
| Cash And Equivalents | 58.03 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 68.69 M | ||||
| Debt To Equity | 0.71 % | ||||
| Current Ratio | 4.52 X | ||||
| Book Value Per Share | 2.62 X | ||||
| Cash Flow From Operations | 4.54 M | ||||
| Short Ratio | 2.71 X | ||||
| Earnings Per Share | (0.05) X | ||||
| Target Price | 37.33 | ||||
| Number Of Employees | 451 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 1.64 B | ||||
| Total Asset | 203.73 M | ||||
| Retained Earnings | (291.26 M) | ||||
| Working Capital | 68.61 M | ||||
| Current Asset | 35.05 M | ||||
| Current Liabilities | 3.71 M | ||||
| Net Asset | 203.73 M |
About Axogen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axogen Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axogen Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Axogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.Moving against Axogen Stock
| 0.9 | OTC | Ocumetics Technology Corp | PairCorr |
| 0.83 | ELAB | Elevai Labs Common | PairCorr |
| 0.76 | VVOS | Vivos Therapeutics | PairCorr |
| 0.71 | VNRX | Volitionrx | PairCorr |
| 0.59 | IPD | Impedimed | PairCorr |
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could Axogen diversify its offerings? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Axogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.235 | Return On Assets | Return On Equity |
Investors evaluate Axogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Axogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Axogen's market price to deviate significantly from intrinsic value.
Understanding that Axogen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Axogen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Axogen's market price signifies the transaction level at which participants voluntarily complete trades.